Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
Mandeep R MehraSapan S DesaiSreyRam KuyTimothy D HenryAmit N PatelPublished in: The New England journal of medicine (2020)
Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with Covid-19. Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. (Funded by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital.).
Keyphrases
- cardiovascular disease
- coronavirus disease
- sars cov
- adverse drug
- healthcare
- cardiovascular events
- type diabetes
- polycystic ovary syndrome
- cardiovascular risk factors
- emergency department
- metabolic syndrome
- coronary artery disease
- pregnant women
- respiratory syndrome coronavirus
- climate change
- human health
- insulin resistance